Advice
Following an abbreviated submission.
Somatropin (Genotropin™) injection is accepted for restricted use within NHS Scotland for the treatment of growth disturbance (current height Standard Deviation Score (SDS) <-2.5 and parental adjusted height SDS <-1) in short children born small for gestational age (SGA), with a birth weight and/or length below -2 Standard Deviations, who failed to show catch-up growth (height velocity SDS < 0 during the last year) by 4 years of age or later.
Treatment should be initiated and monitored by a paediatrician with expertise in managing childhood growth disorders and growth hormone therapy.
Download detailed advice27KB (PDF)
Medicine details
- Medicine name:
- Somatropin (Genotropin®) injection
- SMC ID:
- 240/06
- Indication:
- Growth disturbance
- Pharmaceutical company
- Pfizer Ltd
- BNF chapter
- Endocrine system
- Submission type
- Abbreviated
- Status
- Superseded
- Date advice published
- 13 March 2006